Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Polycystic ovary syndrome affects health and can be hard to diagnose, with treatments ranging from drugs to herbal remedies.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Antiandrogens block male hormones and are not safe during pregnancy.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

AGA might indicate higher risk for severe COVID-19.

Anti-androgens can help reduce the effects of male hormones on the skin.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.